HHC before the ban - All information about possession & consumption

HHC vor dem Verbot - Alle Infos zum Besitz & Konsum
Bea Goldmann CBD specialist author

Bea Goldman

Specialist author with a master’s degree in naturopathy and complementary medicine


There is a significant development in the world of cannabinoids, particularly concerning hexahydrocannabinol (HHC). Recently, on December 4, 2023, a crucial meeting of the Expert Committee on Narcotics and New Psychoactive Substances took place in Bonn. The topics discussed there could have far-reaching consequences for the availability of HHC in Germany, as can be seen from the results published on December 19, 2023.

Background of the Committee of Experts

The independent expert committee on narcotics and new psychoactive substances is an essential part of the political and legislative process in Germany, particularly in the area of ​​drug policy. This committee is made up of experts from various disciplines, including doctors, pharmacologists, lawyers and social scientists. Its main task is to advise the federal government based on scientific findings and current research results.

The Committee's role is particularly relevant when it comes to the classification and regulation of substances that may pose a risk to public health. The committee's experts assess the pharmacological properties, abuse potential and associated risks of new substances. Their recommendations serve as a basis for political decisions that often have far-reaching effects on the availability and legal status of certain substances.

At the December 4, 2023 meeting, the committee's focus was on considering cannabinoids such as HHC, HHCP, THCP, THCV and H4CBD . These substances are part of a rapidly evolving category of new psychoactive substances that require particular attention due to their synthetic nature and potential health risks.

The decisions and recommendations of this committee are particularly important because they not only influence the legal framework, but can also have far-reaching consequences for the pharmaceutical industry, the healthcare sector and consumers. The debates and results of the meetings often set the tone for the future direction of drug policy in Germany and can become the basis for the inclusion of new substances in the New Psychoactive Substances Act (NpSG).

The work of the Committee of Experts is therefore crucial in striking the balance between ensuring public safety and health and protecting individual freedoms and rights in relation to the use and regulation of psychoactive substances. Their expertise and recommendations are key to formulating a responsible and evidence-based drug policy in Germany.

Recommendations and possible consequences

The recommendations of the Expert Committee on Narcotics and New Psychoactive Substances have a significant impact on the legal framework and the handling of cannabinoids such as hexahydrocannabinol (HHC) in Germany. The Committee's discussions and decisions, particularly at the meeting on December 4, 2023, could have a decisive impact on the course and future of HHC regulation.

Integration of HHC into the NpSG

The recommendation to include HHC in Appendix Number 2 of the New Psychoactive Substances Act (NpSG) indicates that stricter regulation is imminent. This measure would place HHC alongside other synthetic cannabinoids and could lead to a ban or at least a severely limited availability of HHC in Germany.

Possible legal changes

The inclusion of HHC in the NpSG would place its sale, possession and consumption under new legal regulations. This could range from complete illegalization to strict control and regulation. Such changes would affect not only consumers, but also manufacturers, retailers and medical professionals.

A ban or strict regulation of HHC would have far-reaching consequences for the cannabis industry. Companies that specialize in the production and distribution of HHC-based products would have to adapt their business models. Consumers who use HHC for medical or recreational purposes may be forced to switch to other substances.

The committee's recommendations also reflect concerns about the health impacts of HHC. Stricter regulations aim to protect public health by minimizing potential risks from consuming synthetic cannabinoids. However, this could also limit the research and medical application of HHC.

Overall, the recommendations of the expert committee and the possible consequences resulting from them are an important step in the development of drug policy in Germany. They underline the need for careful monitoring and regulation of new psychoactive substances in the interest of public health and safety.

Our attitude to HHC

At Shinygram, we closely monitor developments surrounding HHC and are committed to responsible use of cannabinoids. We strive to provide our community with comprehensive information and represent their interests. Despite the existing uncertainties surrounding HHC, we are eagerly awaiting the federal government's decisions and assure that we will continue to offer high-quality, safe and legal products. We are very convinced of natural cannabinoids and therefore offer CBD in the form of oils.

Comparison with CBD

The discussions surrounding the potential regulation or ban of HHC shed light on the stark difference between synthetic cannabinoids such as HHC and naturally occurring cannabinoids such as cannabidiol (CBD). This comparison is crucial to understanding the potential impact of regulatory measures on the cannabinoid market.

While HHC is a synthetically modified cannabinoid, CBD is extracted directly from the cannabis plant. This natural origin of CBD is a key factor that differentiates it from HHC and other synthetic cannabinoids. CBD is valued for its therapeutic properties, without the psychoactive effects often associated with THC and synthetic cannabinoids.

Legally, CBD is in a different category than HHC. While HHC may be subject to strict regulation or a ban, CBD remains largely legal. This is because CBD is non-psychoactive and there is less concern about abuse and health risks. This has led to CBD being legalized in many countries, including Germany.

CBD and HHC also differ in their effect profile. While HHC has similar psychoactive properties to THC, CBD is known for its calming, anti-inflammatory, and pain-relieving properties without getting users high. These properties make it an attractive option for those seeking the therapeutic benefits of cannabinoids without the psychoactive effects.

CBD has firmly established itself on the market and enjoys a positive image, especially with regard to health and wellness. In contrast, HHC is relatively new and is often viewed with some caution, both by consumers and regulators. This difference in perception and acceptance influences consumer decisions and the direction of market development.

The current discussion surrounding HHC could have long-term implications for the cannabinoid market, particularly in terms of research, development and consumer demand. While CBD remains a popular and accepted product, future developments surrounding HHC and other synthetic cannabinoids could change the landscape.

Recommendations for action in the event of a possible HHC ban

It is advisable to thoroughly educate yourself about cannabinoids such as CBD and HHC and weigh the potential pros and cons. CBD is less potent than HHC, and it remains to be seen what decisions will be made regarding other synthetic cannabinoids.


It is important to us to inform you that CBD oil , one of our main products, is completely legal and available without restrictions. The legal situation surrounding CBD has developed significantly in recent years and we are pleased to confirm that CBD products are no longer prohibited and are offered in high quality in our shop. It has established itself on the market and is not a new cannabinoid like HHC.

Our range of CBD oils have been carefully selected to ensure you receive the highest quality products that are both safe and effective. We are always striving to expand our offerings and offer you the best options on the market.

If you have any questions or require further information, please do not hesitate to contact us. Our team is always ready to provide you with advice and support and keep you up to date on the latest developments in CBD and related health topics.

Your health and well-being are of the utmost importance to us. We warmly invite you to visit our shop and discover our range of high-quality CBD oils. We look forward to continuing to support and accompany you in the future.

Reading next

THCV Blüten und Öle
THC Vapes Vorteile und Nachteile

Leave a comment

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bea Goldmann, M.sc.

Bea Goldmann, our experienced specialist author with a master's degree in naturopathy and complementary medicine. Bea is the heart of our content because she not only brings in-depth knowledge, but also a passion for holistic health solutions.

Thanks to Bea's deep understanding of the power of nature and the science behind CBD, we can offer you content that not only informs, but also inspires. With every article she writes for CBD Shinygram, you will not only get insights into the benefits and uses of CBD, but also practical tips on how you can integrate CBD into your everyday life.

Find out more about Bea Goldmann